Skip to content

The Effect of Tecar Therapy on Peripheral Neuropathy in Patients with Type II Diabetes

Comparison of the Effectiveness of Infrared radiation and Tecar Therapy with Infrared radiation on Peripheral Neuropathy in Patients with Type II Diabetes

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190726044337N1
Enrollment
24
Registered
2019-10-20
Start date
2019-04-08
Completion date
Unknown
Last updated
2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type II Diabetes. Type 2 diabetes mellitus with neurological complications

Interventions

Intervention 1: Intervention group: Patients in this group are treated with Infrared radiation (electromagnetic fields with 890 nanometers ,70-80 centimeters away from the surfaces of the foot) for 60
except that the current intensity is zero.

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Age: 18-75 The least duration of illness affliction was more than six months Patients have type II diabetes Mellitus with signs and Symtoms of mild(I) to moderate(II) Peripheral Neuropathy Pain Intensity which was based on VAS (Visual Analog Scale) scores were more than three

Exclusion criteria

Exclusion criteria: Pregnancy Diabetic Infectious Wound Involvement of Cardiovascular system Involvement of Respiratory system To have Pace maker

Design outcomes

Primary

MeasureTime frame
Intensity of pain. Timepoint: Before treatment, after ten session, Follow up for six weeks. Method of measurement: Base on visual analogue scale.

Secondary

MeasureTime frame
Tactile sensation of feet. Timepoint: Before treatment, After ten session, Follow up for six weeks. Method of measurement: Monofilament 5.07/10 g.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Niajalili

Shahid Beheshti University of Medical Sciences

Maryam_Niajalili@sbmu.ac.ir+98 13 4222 4593

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026